Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 639, Issue 1-2, 2008, Pages 1-10

  Shah, Parag P ^a   Singh, Arvind P ^a   Singh, Madhu ^a   Mathur, Neeraj ^a   Pant, Mohan C ^b   Mishra, Bhartendu N ^c   Parmar, Devendra ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

^c INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

CYP1A1; Gene environment; Gene gene; Interaction; Lung cancer; Polymorphism

Indexed keywords

ALCOHOL; CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CIGARETTE SMOKING; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; ENVIRONMENT; ENZYME POLYMORPHISM; FEMALE; GENE INTERACTION; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MASTICATION; MUTANT; NULL ALLELE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROTEIN INTERACTION; RISK FACTOR; SEX; TOBACCO; UNIVERSITY;

ADULT; ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; DISEASE SUSCEPTIBILITY; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; TOBACCO USE DISORDER;

NICOTIANA TABACUM;

EID: 39249085275     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.10.006     Document Type: Article

References (52)

1. Gupta D., Boffatta P., Gaborieau V., and Jindal S.K. Risk factors of lung cancer in Chandigarh, India. J. Med. Res. 113 (2001) 142-150
2. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 14 (1999) 1194-1210
3. Inoue K., Asao T., and Shimada T. Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations. Xenobiotica 30 (2000) 285-295
4. Shimada T., Hayes C.L., Yamazaki H., Amin S., Hecht S.S., Guengerich F.P., and Sutter T.R. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56 (1996) 2979-2984
5. Barouki R., and Morel Y. Repression of cytochrome P450 1A1 gene expression by oxidative stress: mechanisms and biological implications. Biochem. Pharmacol. 61 (2001) 511-516
6. Quinones L., Lucas D., Godoy J., Caceres D., Berthou F., Varela N., Lee K., Acevedo C., Martinez L., Aguilera A.M., and Gil L. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett. 174 (2001) 35-44
7. Schneider J., Bernges U., Philipp M., and Woitowitz H.J. CYP1A1 and CYP1B1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Genomics Proteomics (2004) 189-198
8. Hayashi S., Watanabe J., Nakachi K., and Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J. Biochem. 110 (1991) 407-411 (Tokyo)
9. Kawajiri K., Eguchi H., Nakachi K., Sekiya T., and Yamamoto M. Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res. 56 (1996) 72-76
10. d'Errico A., Malats N., Vineis P., and Boffetta P. Review of studies of selected metabolic polymorphisms and cancer. IARC Sci. Publ. 148 (1999) 323-393
11. Strange R.C., and Fryer A.A. The glutathione-S-transferases: influence of polymorphism on cancer susceptibility. In: Vineis P., Malats N., Lang M., d'Errico A., Caporaso N., Cuzick J., and Boffetta P. (Eds). Metabolic Polymorphisms and Susceptibility to Cancer vol. 148 (1999), IARC Scientific Publications, Lyon, France pp. 231-249
12. Antilla S., Kalina I., Marchand Le., London S.J., Rannug A., Romkes M., Salagovic J., Schoket B., Gaspari L., Taioli E., Hung R.J., Boffetta P., Brockmoller J., Butkiewicz D., Cascorbi I., Clapper M.L., Garte S., Haugen A., and Hirvonen A. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasians non-smokers: a pooled analysis. Carcinogenesis 24 (2003) 875-882
13. Song N., Tan W., Xing D., and Lin D. CYP1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis 22 (2002) 11-16
14. Hung R.J., Boffetta P., Brockmoller J., Butkiewicz D., Cascorbi I., Clapper M.L., Garte S., Haugen A., Hirvonen A., Anttila S., Kalina I., Le Marchand, London S.J., Rannug A., Romkes M., Salagovic J., Schoket B., Gaspari L., and Taioli E. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis 24 (2003) 875-882
15. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., and Autrup H. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomark. Prev. 10 (2001) 1239-1248
16. Hong Y.S., Chang J.H., Kwon O.J., Ham Y.A., and Choi J.H. Polymorphism of the CYP1A1 and glutathione-S-transferase gene in Korean lung cancer patients. Exp. Mol. Med. 30 (1998) 192-198
17. Sugimura H., Wakai K., Genka K., Nagura K., Igarashi H., Nagayama K., Ohkawa A., Baba S., Morris B.J., Tsugane S., Ohno Y., Gao C., Li Z., Takezaki T., Tajima K., and Iwamasa T. Association of Ile462Val (exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: further evidence from a case-control study in Okinawa. Cancer Epidemiol. Biomark. Prev. 7 (1998) 413-417
18. Song N., Tan W., Xing D., and Lin D. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis 22 (2001) 11-16
19. Shields P.G., Caporaso N.E., Falk R.T., Sugimura H., Trivers G.E., Trump B.F., Hoover R.N., Weston A., and Harris C.C. Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiol. Biomark. Prev. 2 (1993) 481-485
20. Bouchardy C., Wikman H., Benhamou S., Hirvonen A., Dayer P., and Pursiainen K.H. CYP1A1 genetic polymorphisms, tobacco smoking and lung cancer risk in a French Caucasian population. Biomarkers 2 (1997) 131-134
21. Wenzlaff A.S., Cote M.L., Bock C.H., Land S.J., Santer S.K., Schwartz D.R., and Schwartz A.G. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 26 (2005) 2207-2212
22. Benhamou S., Lee W.J., Alexandrie A.K., Boffeta P., Bouchardy C., and Butkiewicz D. Meta and pooled analyses of the effects of glutathione-S-transferases M1 polymorphism and smoking on lung cancer risk. Carcinogenesis 23 (2002) 1343-1350
23. Vineis P., Malats M., Lang M., d'Errico A., Caporaso N., Cuzick J., and Boffetta P. Metabolic polymorphisms and susceptibility to cancer eds. IARC Sci. Publ. 148 (1999) 1-510
24. Yang X.R., Wacholder S., Xu Z., Dean M., Clark V., Gold B., Brown L.M., Stone B.J., Fraumeni J.F., and Caporaso N.E. CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women. Cancer Lett. 214 (2004) 197-204
25. Sobti R.C., Sharma S., Joshi A., Jindal S.K., and Janmeja A. CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population. Biomarkers 8 (2003) 415-428
26. Sobti R.C., Sharma S., Joshi A., Jindal S.K., and Janmeja A. Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a North Indian population. Mol. Cell Biochem. 266 (2004) 1-9
27. Sreeja L., Syamala V., Hariharan S., Madhavan J., Devan S.C., and Ankathil R. Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J. Hum. Genet. 50 (2005) 618-627
28. Oyama T., Mitsudomi T., Kawamoto T., Ogami A., Osaki T., Kodama, and Yasumoto Y. Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. Int. Arch. Occup. Environ. Health 67 (1995) 253-256
29. Cascorbi I., Brockmoller J., and Roots I. A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res. 56 (1996) 4965-4969
30. Zhong S., Howie A., Ketterer B., Taylor J., Hayes J.D., Beckette G., Wathen C.G., Wolf C.R., and Spurr N.K. Glutathione-S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 12 (1991) 1533-1537
31. Hung H.C., Chuang J., Chien Y.C., Chern H.D., Chiang C.P., Kuo Y.S., Chen A., and Hildesheim C.J. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; Environmental factors and risk of oral cancer. Cancer Epidemiol. Biomark. Prev. 6 (1997) 901-905
32. Sikdar N., Mahmud S.K., Paul R.R., and Roy B. Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett. 195 (2003) 33-42
33. De Ruyck K., Szaumkessel M., De Rudder I., Dehoorne A., Vral A., Claes K., Velghe A., Meerbeeck J.V., and Thierens H. Polymorphism in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat. Res. 631 (2007) 101-110
34. Vineis P., Veglia F., Benhamou S., Butkiewicz D., Cascorbi I., Clapper M.L., Dolzan V., Haugen A., Hirvonen A., Ingelman-Sundberg M., Kihara M., Kiyohara C., Kremers P., Le Marchand, Ohshima S., Pastorelli R., Rannug A., Romkes M., Schoket B., Shields P., Strange R.C., Stucker I., Sugimura H., Garte S., Gaspari L., and Taioli E. CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int. J. Cancer 104 (2003) 650-657
35. Hirvonen A., Husgafvel-Pursiainen K., Karjalainen A., Anttila S., and Vainio H. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol. Biomark. Prev. 1 (1992) 485-489
36. Drakoulis N., Cascorbi I., Brockmoller J., Gross C.R., and Roots I. Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3′-flanking region. Clin. Investig. 72 (1994) 240-248
37. Taioli E., Gaspari L., Benhamou S., Boffetta P., Brockmoller J., Butkiewicz D., Carcorbi I., Clapper M.L., Dolzan V., Haugen A., Hirvonen A., Husgafvel-Pursisinen K., Kalina I., Kremers P., Le Marchand, London S., Rannug A., Romkes M., Schoket B., Seidegard J., Strange R.C., Stucker I., To-Figueras J., and Garte S. Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int. J. Epidemiol. 32 (2003) 60-63
38. Dialyna I.A., Miyakis S., Georgatou N., and Spandidos Da. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk. Oncol. Rep. 10 (2003) 1829-1835
39. Nakachi K., Imai K., Hayashi S., and Kawajiri K. Polymorphisms of the CYP1A1 and glutathione-S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res. 53 (1993) 2994-2999
40. Kihara M., Kihara M., and Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 16 (1995) 2331-2336
41. Lee E.J., Zhao B., Moochhala S.M., and Ngoi S.S. Frequency of mutant CYPIA1, NAT2 and GSTM1 alleles in a normal Chinese population. Pharmacogenetics 4 (1994) 355-358
42. Zhao B., Lee E.J., Wong J.Y., Yeoh P.N., and Gong N.H. Frequency of mutant CYP1A1, NAT2 and GSTM1 alleles in normal Indians and Malays. Pharmacogenetics 5 (1995) 275-280
43. Le Marchand, Guo C., Benhamou S., Bouchardy C., Cascorbi I., Clapper M.L., Garte S., Haugen A., Ingelman-Sundberg M., Kihara M., Rannug A., Ryberg D., Stucker I., Sugimura H., and Taioli E. Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control 14 (2003) 339-346
44. Singh V., Rastogi N., Sinha A., Kumar A., Mathur N., and Singh M.P. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women. Breast Cancer Res. Treat. 101 (2007) 73-81
45. Schwarz D., Kisselev P., Cascorbi I., Schunck W.H., and Roots I. Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants. Carcinogenesis 22 (2001) 453-459
46. Chang B.L., Zheng S.L., Isaacs S.D., Turner A., Hawkins G.A., Wiley K.E., Bleecker E.R., Walsh P.C., Meyers D.A., Isaacs W.B., and Xu J. Polymorphism in the CYP1A1 gene is associated with prostate cancer risk. Int. J. Cancer 106 (2003) 375-378
47. Chen S., Xue K., Xu L., Ma G., and Wu J. Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population. Mutat. Res. 458 (2001) 41-47
48. IARC. Monograph on the evaluation of the carcinogenic risk of chemicals to humans-tobacco smoking. IARC Sci. Publ. 38 (1986) 1-3
49. Dikshit R.P., and Kanhere S. Tobacco habits and risk of lung, oropharyngeal and oral cavity cancer: a population-based case-control study in Bhopal, India. Int. J. Epidemiol. 29 (2000) 609-614
50. Gajalakshmi V., Hung R.J., Mathew A., Varghese C., Brennan P., and Boffetta P. Tobacco smoking and chewing, alcohol drinking and lung cancer risk among men in southern India. Int. J. Cancer 107 (2003) 441-447
51. Bhurgri Y., Decullier E., Bhurgri A., Nassar S., Usman A., Brennan P., and Boffetta P. A case-control study of lung cancer in Karachi, Pakistan. Int. J. Cancer 98 (2002) 952-955
52. Freudenheim J.L., Ritz J., Smith-Warner S.A., Albanes D., Bandera E.V., van den Brandt P.A., Colditz G., Feskanich D., Goldbohm R.A., Harnack L., Miller A.B., Rimm E., Rohan T.E., Sellers T.A., Virtamo J., Willett W.C., and Hunter D.J. Alcohol consumption and risk of lung cancer: a pooled analysis of cohort studies. Am. J. Clin. Nutr. 82 (2005) 657-667